Investor Presentation for the Audited Financial Results for the quarter and year ended March 31, 2026.
TRUALT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TruAlt Bioenergy reported FY26 standalone total income of ₹1,772.94 Cr (down 8.64% YoY), with PAT declining 43.09% to ₹80.03 Cr. Q4 FY26 standalone revenue fell 32.46% YoY to ₹616.62 Cr. The ethanol segment faced significant headwinds with OMCs sharply reducing lifting despite full operational capacity, causing severe underutilisation across the sector. The company completed dual-feed integration (1,300 KLPD of 2,000 KLPD capacity) transitioning toward year-round operations. A ₹1,062 crore pending allocation (~15 crore litres) was secured via Karnataka High Court order. CBG segment showed strong growth with PAT up 185% YoY to ₹18.06 Cr for FY26. The company operates 5 ethanol units (2,000 KLPD), 1 operational CBG plant with 4 under construction, and 7 retail fuel outlets (4 under construction).
The stock faces pressure from weak ethanol offtake and declining profits, though the court victory for ₹1,062 crore pending allocation and strong CBG growth provide recovery potential. Higher blending targets (E22-E30) and policy tailwinds should support long-term demand.